Literature DB >> 33552062

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.

Jianfen Meng1,2, Yuning Ma1, Jinchao Jia1, Mengyan Wang1, Jialin Teng1, Hui Shi1, Honglei Liu1, Yutong Su1, Junna Ye1, Yue Sun1, Xiaobing Cheng1, Huihui Chi1, Tingting Liu1, Dehao Zhu1, Zhuochao Zhou1, Liyan Wan1, Zhihong Wang1, Fan Wang1, Xin Qiao1, Xia Chen1, Hao Zhang1, Zihan Tang1, Chengde Yang1, Qiongyi Hu1.   

Abstract

The catastrophic outbreak of coronavirus disease 2019 (COVID-19) is currently a public emergency. Adult-onset Still's disease (AOSD) is an autoinflammatory disease characterized by life-threatening complications. Systemic hyperinflammation and cytokine storm play a critical role in the pathogenesis of both COVID-19 and AOSD. We aimed to compare the similarities and differences focusing on ferritin and cytokine levels between severe COVID-19 and active AOSD. A literature search was performed using the databases PubMed, EMBASE, and Web of Science to collect the levels of cytokine including IL-1β, IL-6, IL-18, TNF-α, IL-10, and ferritin in severe COVID-19 patients. After extracting available data of indicators of interest, we acquired these statistics with a single-arm meta-analysis. Furthermore, a comparison was conducted between 52 patients with active AOSD in our center and severe COVID-19 patients from databases. The levels of IL-6 and IL-10 were higher in severe COVID-19 compared with those in active AOSD. There were no significant differences on the cytokine of IL-1β and TNF-α. Fold changes of IL-18 were defined as the mean expression level ratio of severe COVID-19 to healthy controls in the COVID-19 study and active AOSD to healthy controls in our study, individually. Although the fold change of IL-18 in patients with AOSD was significantly higher than patients with severe COVID-19 (fold change: 594.00 vs 2.17), there was no statistical comparability. In addition, the level of ferritin was higher in active AOSD in comparison with severe COVID-19. Our findings suggest that severe COVID-19 and active AOSD have differences in cytokine panel and ferritin level, indicating the pathogenic role of ferritin in overwhelming inflammation. And it paves the way to make efficacy therapeutic strategy targeting the hyperinflammatory process in COVID-19 according to AOSD management, especially in severe COVID-19.
Copyright © 2021 Meng, Ma, Jia, Wang, Teng, Shi, Liu, Su, Ye, Sun, Cheng, Chi, Liu, Zhu, Zhou, Wan, Wang, Wang, Qiao, Chen, Zhang, Tang, Yang and Hu.

Entities:  

Keywords:  adult-onset Still’s disease; coronavirus disease 2019; cytokine storm; hyperferritinemia; inflammation

Year:  2021        PMID: 33552062      PMCID: PMC7856388          DOI: 10.3389/fimmu.2020.603389

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  8 in total

1.  The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.

Authors:  Shima Makaremi; Ali Asgarzadeh; Hamed Kianfar; Alireza Mohammadnia; Vahid Asghariazar; Elham Safarzadeh
Journal:  Inflamm Res       Date:  2022-06-25       Impact factor: 6.986

Review 2.  Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.

Authors:  Giuliana Galassi; Alessandro Marchioni
Journal:  J Clin Neurosci       Date:  2022-04-29       Impact factor: 2.116

Review 3.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21

Review 4.  Two flares of Still's disease after two doses of the ChAdOx1 vaccine.

Authors:  Rashmi Roongta; Sumantro Mondal; Subhankar Haldar; Mavidi Sunil Kumar; Alakendu Ghosh
Journal:  Clin Rheumatol       Date:  2022-03-06       Impact factor: 3.650

Review 5.  Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae.

Authors:  Gustavo Ramírez-Martínez; Luis Armando Jiménez-Álvarez; Alfredo Cruz-Lagunas; Sergio Ignacio-Cortés; Itzel Alejandra Gómez-García; Tatiana Sofia Rodríguez-Reyna; José Alberto Choreño-Parra; Joaquín Zúñiga
Journal:  J Interferon Cytokine Res       Date:  2022-05-31       Impact factor: 3.657

Review 6.  Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?

Authors:  Nithin K K; Prakash Patil; Satheesh Kumar Bhandary; Vikram Haridas; Suchetha Kumari N; Sarathkumar E; Praveenkumar Shetty
Journal:  F1000Res       Date:  2021-04-06

Review 7.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

Review 8.  New-onset Adult-onset Still's disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature.

Authors:  Shivraj Padiyar; Navaneeth Kamath; John Mathew; A S Chandu; Divya Deodhar; B A Shastry; T Shashikala; Arvind Ganapati
Journal:  Clin Rheumatol       Date:  2022-01-18       Impact factor: 3.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.